56 89

Cited 0 times in

Sjögren Syndrome after Radioiodine Therapy in Thyroid Cancer Patients

Authors
 Hee Jin Lee  ;  Jae-Jeong Kim  ;  Young-Gun Kim  ;  Hyung-Joon Ahn  ;  Jong-Hoon Choi  ;  Jeong-Seung Kwon 
Citation
 Journal of Oral Medicine and Pain, Vol.43(3) : 84-86, 2018 
Journal Title
 Journal of Oral Medicine and Pain 
ISSN
 2288-9272 
Issue Date
2018
Keywords
Sjögren’s syndrome ; Thyroid neopla는 ; Xerostomia
Abstract
Salivary and lacrimal gland dysfunction is relatively frequent after radioiodine therapy. In most cases this is a transient side effect, but in some patients it may persist for a long period or appear late. Radioiodine (¹³¹I) therapy is often administered to patients following total thyroidectomy to treat well-differentiated follicular cell-derived thyroid cancer. In addition to the thyroid, ¹³¹I accumulates in the salivary glands, giving rise to transient or permanent salivary gland damage. Salivary gland dysfunction following radioiodine therapy can be caused by radiation damage. But, it also may be associated with Sjögren syndrome (SS) developed after radioiodine therapy. It would be recommended that the evaluation for SS including anti-SSA/ Ro and anti-SSB/La should be considered before and after radioiodine therapy.
Files in This Item:
T201803923.pdf Download
DOI
10.14476/jomp.2018.43.3.84
Appears in Collections:
2. College of Dentistry (치과대학) > Dept. of Orofacial Pain and Oral Medicine (구강내과학교실) > 1. Journal Papers
Yonsei Authors
권정승(Kwon, Jeong Seung) ORCID logo https://orcid.org/0000-0003-4584-7355
김영건(Kim, Young Gun)
최종훈(Choi, Jong Hoon) ORCID logo https://orcid.org/0000-0003-3211-3619
Export
RIS (EndNote)
XLS (Excel)
XML
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/165050
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse